| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |